|
|
High-Content Analysis Market OutlookPublished by: CHI Insight Pharma Reports Published: Mar. 1, 2004 - 36 Pages Table of ContentsExecutive Summary Chapter 1. Introduction Chapter 2. High-Throughput Screening Discussion 2.1 Introduction -Rising R&D Costs - Accelerating Discovery through High-Throughput 2.2 Current High-Throughput Screening Market Breakdown -High-Throughput Screening Market Trends 2.3 High-Content Analysis 2.4 Conclusion Chapter 3. High-Content Analysis Overview 3.1 State of Cell Based Assays in Drug Development - Where Does High Content Analysis Fit? -High-Content Analysis Customer Description 3.2 Current Needs, Most Valuable Assays, Best Opportunities for High-Content Analysis -GPCR -RNAi 3.3 Technical Considerations -Time to Scan -Sample Preparation -Fixed Versus Kinetic Studies 3.4 Market Conditions -Hardware Market Analysis Chapter 4. High-Content Analysis Impact 4.1 Impact o n Systems Biology 4.2 Impact on Toxicology Chapter 5. Market Change Analysis - Five Year Projections 5.1 High-Content Analysis Hardware System Model 5.2 Reagent Cost Model 5.3 Other Costs 5.4 Total Market 5.5 Challenges to Technology Adoption 5.6 Conclusion Appendix. Companies Interviewed Applied Precision AstraZeneca Atto Bioscience Aventis Axon Bristol-Myers Squibb Cellomics ICCB (Harvard Medical School) Molecular Devices Pfizer Roche Schering-Plough Wyeth Glossary Company Index AbstractHigh-Content Analysis Market Outlook quantifies the current and future market size for high-content a nalysis (HCA) systems, software, and reagents. Key areas of implementation and growth potential, as well as areas of future development that will also impact the overall market size, are identified and analyzed.Get Full Details About This Report >> |
|
|||
|
About MarketResearch.com
|
||||